J Z Kostro1, A Hellmann2, J Kobiela2, I Skóra3, M Lichodziejewska-Niemierko4, A Dębska-Ślizień5, Z Śledziński2. 1. Department of General, Endocrine, and Transplant Surgery, Medical University of Gdańsk, Poland. Electronic address: kostro@gumed.edu.pl. 2. Department of General, Endocrine, and Transplant Surgery, Medical University of Gdańsk, Poland. 3. Regional Transplant Coordination Centre, UCK Gdańsk, Poland. 4. Department of Palliative Medicine, Medical University of Gdańsk, Poland. 5. Department of Nephrology, Transplantology, and Internal Medicine, Medical University of Gdańsk, Poland.
Abstract
BACKGROUND: The purpose of renal transplantation is to achieve a maximal improvement in quality of life (QoL) and life expectancy in patients with end-stage renal disease (ESRD) while minimizing the potential side effects of this procedure. It is important to achieve an optimal balance between graft function and the patient's QoL. This study was designed to assess the changes in the QoL after kidney transplantation (KTx) in patients with ESRD previously treated with hemodialysis (HD) or peritoneal dialysis (PD). METHODS: QoL was prospectively analyzed in 69 patients after kidney transplantation in a single-center study. Patients with ESRD were divided into 2 groups: those previously treated with HD (n = 44 patients; group 1) or PD (n = 25 patients; group 2). Both groups were asked to complete the KDQOL-SFtm questionnaire before and 12 months after kidney transplantation. RESULTS: We observed significant differences in many parameters of QoL in both groups after KTx but more positive changes of most parameters in question exhibited by patients previously treated by means of HD than PD. Patients treated with HD and PD demonstrated improvement after KTx in 74% of dimensions. There were no statistical differences in the QoL between group 1 and group 2 before or after KTx. CONCLUSIONS: The study demonstrated post- to pre-transplant improvements of QoL independently of previous treatment.
BACKGROUND: The purpose of renal transplantation is to achieve a maximal improvement in quality of life (QoL) and life expectancy in patients with end-stage renal disease (ESRD) while minimizing the potential side effects of this procedure. It is important to achieve an optimal balance between graft function and the patient's QoL. This study was designed to assess the changes in the QoL after kidney transplantation (KTx) in patients with ESRD previously treated with hemodialysis (HD) or peritoneal dialysis (PD). METHODS: QoL was prospectively analyzed in 69 patients after kidney transplantation in a single-center study. Patients with ESRD were divided into 2 groups: those previously treated with HD (n = 44 patients; group 1) or PD (n = 25 patients; group 2). Both groups were asked to complete the KDQOL-SFtm questionnaire before and 12 months after kidney transplantation. RESULTS: We observed significant differences in many parameters of QoL in both groups after KTx but more positive changes of most parameters in question exhibited by patients previously treated by means of HD than PD. Patients treated with HD and PD demonstrated improvement after KTx in 74% of dimensions. There were no statistical differences in the QoL between group 1 and group 2 before or after KTx. CONCLUSIONS: The study demonstrated post- to pre-transplant improvements of QoL independently of previous treatment.
Authors: Bénédicte Sautenet; Allison Tong; Karine E Manera; Jeremy R Chapman; Anthony N Warrens; David Rosenbloom; Germaine Wong; John Gill; Klemens Budde; Lionel Rostaing; Lorna Marson; Michelle A Josephson; Peter P Reese; Timothy L Pruett; Camilla S Hanson; Donal O'Donoghue; Helen Tam-Tham; Jean-Michel Halimi; Jenny I Shen; John Kanellis; John D Scandling; Kirsten Howard; Martin Howell; Nick Cross; Nicole Evangelidis; Philip Masson; Rainer Oberbauer; Samuel Fung; Shilpa Jesudason; Simon Knight; Sreedhar Mandayam; Stephen P McDonald; Steve Chadban; Tasleem Rajan; Jonathan C Craig Journal: Transplantation Date: 2017-08 Impact factor: 4.939
Authors: Bernard J DuBray; Saed H Shawar; Scott A Rega; Kristin M Smith; Kaylin M Centanni; Kara Warmke; Beatrice P Concepcion; Gretchen C Edwards; Heidi M Schaefer; Irene D Feurer; Rachel C Forbes Journal: Kidney360 Date: 2020-10-30
Authors: William N Robiner; Megan L Petrik; Nancy Flaherty; Thyra A Fossum; Rebecca L Freese; Thomas E Nevins Journal: J Clin Psychol Med Settings Date: 2021-06-04
Authors: Kjersti Lønning; Kristian Heldal; Tomm Bernklev; Cathrine Brunborg; Marit Helen Andersen; Nanna von der Lippe; Anna Varberg Reisæter; Pål-Dag Line; Anders Hartmann; Karsten Midtvedt Journal: Transplant Direct Date: 2018-03-01